tert-butyl 4-(butylthiocarbonothioyl)piperazine-1-carboxylate | 1605349-63-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: tert-butyl 4-(butylthiocarbonothioyl)piperazine-1-carboxylate
• 英文别名: tert-butyl4-(butylthiocarbonothioyl)piperazine-1-carboxylate
• CAS: 1605349-63-0
• 化学式: C₁₄H₂₆N₂O₂S₂
• 分子量: 318.505
• InChiKey: RHODWZFPBRSHHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.36
• 重原子数：
  20.0
• 可旋转键数：
  3.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  32.78
• 氢给体数：
  0.0
• 氢受体数：
  4.0

反应信息

• 作为反应物：
  描述：

  tert-butyl 4-(butylthiocarbonothioyl)piperazine-1-carboxylate 在 三乙胺 、 三氟乙酸 、 sodium hydroxide 作用下， 以 甲醇 、 二氯甲烷 、 水 、 乙酸乙酯 为溶剂， 反应 23.0h， 生成 1-butyl 4-(2-hydroxyethyl)piperazine-1,4-bis(carbodithioate)
  参考文献：
  名称：

  新型精子固定剂的设计和合成过程中独特的二硫代氨基甲酸酯化学物质† ‡

  摘要：

  在设计和合成1,4-（二取代）哌嗪二碳二硫代酸酯为双刃杀精剂的过程中，在酸性和碱性条件下，通过不寻常地除去苄基取代的二硫代氨基甲酸酯衍生物中的CS 2来获得1-取代的哌嗪碳二硫代酸酯。已经提出了一种可行的CS 2去除机理。所有合成的化合物均具有杀精，抗滴虫和抗真菌活性。21种化合物不可逆地固定了100％的精子（MEC，0.06-31.6 mM），而7种化合物表现出多种活性。苄基4-（2-（哌啶-1-基）乙基）哌嗪-1-（碳二硫代酸酯）（18）和1-苄基4-（2-（哌啶基-1-基）乙基）哌嗪-1,4-双（碳二硫代）（24）表现出明显的杀精子活性（MEC，0.07和0.06 mM），抗真菌剂（MIC，0.069–0.14和> 0.11 mM）和抗毛滴虫活性（MIC，1.38和0.14 mM）。这些化合物可能的作用方式似乎是通过巯基结合，这通过精子硫醇的荧光标记证实。

  DOI：

  10.1039/c4ob00005f
• 作为产物：
  描述：

  二碳酸二叔丁酯 在 三乙胺 、 sodium hydroxide 作用下， 以 甲醇 、 氯仿 、 乙酸乙酯 为溶剂， 反应 17.0h， 生成 tert-butyl 4-(butylthiocarbonothioyl)piperazine-1-carboxylate
  参考文献：
  名称：

  新型精子固定剂的设计和合成过程中独特的二硫代氨基甲酸酯化学物质† ‡

  摘要：

  在设计和合成1,4-（二取代）哌嗪二碳二硫代酸酯为双刃杀精剂的过程中，在酸性和碱性条件下，通过不寻常地除去苄基取代的二硫代氨基甲酸酯衍生物中的CS 2来获得1-取代的哌嗪碳二硫代酸酯。已经提出了一种可行的CS 2去除机理。所有合成的化合物均具有杀精，抗滴虫和抗真菌活性。21种化合物不可逆地固定了100％的精子（MEC，0.06-31.6 mM），而7种化合物表现出多种活性。苄基4-（2-（哌啶-1-基）乙基）哌嗪-1-（碳二硫代酸酯）（18）和1-苄基4-（2-（哌啶基-1-基）乙基）哌嗪-1,4-双（碳二硫代）（24）表现出明显的杀精子活性（MEC，0.07和0.06 mM），抗真菌剂（MIC，0.069–0.14和> 0.11 mM）和抗毛滴虫活性（MIC，1.38和0.14 mM）。这些化合物可能的作用方式似乎是通过巯基结合，这通过精子硫醇的荧光标记证实。

  DOI：

  10.1039/c4ob00005f

文献信息

• Dithiocarbamate–thiourea hybrids useful as vaginal microbicides also show reverse transcriptase inhibition: Design, synthesis, docking and pharmacokinetic studies
  作者：Veenu Bala、Santosh Jangir、Dhanaraju Mandalapu、Sonal Gupta、Yashpal S. Chhonker、Nand Lal、Bhavana Kushwaha、Hardik Chandasana、Shagun Krishna、Kavita Rawat、Jagdamba P. Maikhuri、Rabi S. Bhatta、Mohammad I. Siddiqi、Rajkamal Tripathi、Gopal Gupta、Vishnu L. Sharma

  DOI：10.1016/j.bmcl.2014.12.062

  日期：2015.2

  Prophylactic prevention is considered as the most promising strategy to tackle STI/HIV. Twenty-five dithiocarbamate-thiourea hybrids (14-38) were synthesized as woman controlled topical vaginal microbicides to counter Trichomonas vaginalis and sperm along with RT inhibition potential. The four promising compounds (18, 26, 28 and 33) were tested for safety through cytotoxic assay against human cervical cell line (HeLa) and compatibility with vaginal flora, Lactobacillus. Docking study of most promising vaginal microbicide (33) revealed that it docked in a position and orientation similar to known reverse transcriptase inhibitor Nevirapine. The preliminary in vivo pharmacokinetics of compound 33 was performed in NZ-rabbits to evaluate systemic toxicity in comparison to Nonoxynol-9. (C) 2014 Elsevier Ltd. All rights reserved.
• Substituted carbamothioic amine-1-carbothioic thioanhydrides as novel trichomonicidal fungicides: Design, synthesis, and biology
  作者：Dhanaraju Mandalapu、Bhavana Kushwaha、Sonal Gupta、Shagun Krishna、Nidhi Srivastava、Mahendra Shukla、Pratiksha Singh、Bhavana S. Chauhan、Ravi Goyani、Jagdamba P. Maikhuri、Koneni V. Sashidhara、Brijesh Kumar、Renu Tripathi、Praveen K. Shukla、Mohammad I. Siddiqi、Jawahar Lal、Gopal Gupta、Vishnu L. Sharma

  DOI：10.1016/j.ejmech.2017.11.060

  日期：2018.1

  Sexually transmitted diseases like trichomoniasis along with opportunistic fungal infections like candidiasis are major global health burden in female reproductive health. In this context a novel non-nitroimidazole class of substituted carbamothioic amine-1-carbothioic thioanhydride series was designed, synthesized, evaluated for trichomonacidal and fungicidal activities, and was found to be more active than the standard drug Metronidazole (MTZ). Compounds were trichomonicidal in the MIC ranges of 4.77-294.1 mu M and 32.46-735.20 mu M against MTZ-susceptible and-resistant strains, respectively. Further, compounds inhibited the growth of at least two out of ten fungal strains tested at MIC of 7.50 -240.38 mu M. The most active compound (20) of this series was 3.8 and 9.5 fold more active than the MTZ against the two Trichomonas strains tested. Compound 20 also significantly inhibited the sulfhydryl groups present over Trichomonas vaginalis and was found to be more active than the MTZ in vivo. Further, a docking analysis carried out with cysteine proteases supported their thiol inhibiting ability and preliminary pharmacokinetic study has shown good distribution and systemic clearance. (C) 2017 Elsevier Masson SAS. All rights reserved.